U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Training and Continuing Education
  3. CDERLearn Training and Education
  1. Training and Continuing Education

CDERLearn Training and Education

Learning opportunities for healthcare professionals, academia, students, and consumers

Search General Courses   Search Industry Courses

Upcoming Free CE Opportunities

For Industry

CDERLearn

Use filters and search box to find resources

Advanced search (combine topic and search terms)

Summary Type Topic
The History of FDA Health Care Professional; Webinars Drug Development; Drug Regulatory Process; Drug Safety
Bench to Bedside: Integrating Sex and Gender to Improve Human Health CE Eligible; Health Care Professional; Webinars Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Women's Health
Q&A with FDA Podcasts COVID-19
Biosimilars Level 1: Foundational Concepts Health Care Professional Biosimilars
Biosimilars Level 2: Regulatory and Scientific Concepts Health Care Professional Biosimilars; Drug Regulatory Process
Biosimilars Videos Healthcare Professional; Videos Biosimilars; Drug Regulatory Process
Drug Approval Case Studies Health Care Professional Drug Regulatory Process
FDA’s Role in Public Health: Drug Efficacy, Safety, Quality, and Beyond Health Care Professional; CE Eligible Drug Regulatory Process
Practitioners’ Guide for Improving Oral Anticoagulant Use Health Care Professional; CE Eligible Oral Anticoagulant; Disease States
The FDA Bad Ad Program and Prescription Drug Promotion Health Care Professional; CE Eligible Prescription Drug Promotion
FDA MedWatch and Patient Safety Health Care Professional MedWatch; Drug Safety
The FDA Process for Approving Generic Drugs Health Care Professional Drug Regulatory Process; Drug Development; Generic Drugs
FDA Overview of Biosimilar Products Health Care Professional Biosimilars
Leveraging Health Literacy and Patient Preferences to Reduce Hypoglycemia Events in Patients with Type 2 Diabetes Health Care Professional Diabetes; Disease States
Director's Corner Podcasts Podcasts Drug Regulatory Process; Drug Development
Drug Information Soundcast in Clinical Oncology (D.I.S.C.O) Health Care Professional; Podcasts Cancer Drugs
FDA Drug Safety Podcasts Health Care Professional; Podcasts Drug Safety
Regulatory Science at CDER Podcasts Podcasts Drug Development
FDA's Biomarker Qualification Program Videos Biomarker; Drug Development
Biosimillars Patient and Prescriber Outreach Materials Health Care Professional; Videos Biosimilars; Drug Regulatory Process; Drug Development
FDA Drug Info Rounds Health Care Professional; Videos Drug Safety; MedWatch; IND; Drug Development; Drug Regulatory Process; Prescription Drug Promotion; Disease States; Registration and Listing; Generic Drugs
GDUFA II Videos and Resources Videos Drug Development; Generic Drugs
Regulatory Science at CDER Videos Videos Drug Regulatory Process; Drug Development
Biosimlars Online Courses, Webinars, and Presentations Health Care Professional; Webinars Biosimliars; Drug Regulatory Process; Drug Development
CDER Webinars Health Care Professional; Webinars Drug Regulatory Process; Drug Development; Generic Drugs; OTC Drug Regulations; Registration and Listing; Electronic Submissions; Biosimilars; Drug Safety; MedWatch; IND; Disease States; Prescription Drug Promotion; Cancer Drugs
Division of Drug Information Webinars Health Care Professional; Webinars; CE Eligible Drug Regulatory Process; Drug Development; Generic Drugs; OTC Drug Regulations; Biosimilars; Drug Safety; MedWatch; IND; Disease States; Prescription Drug Promotion; Cancer Drugs
Compounding Quality Center of Excellence On-Demand Training Health Care Professional; Webinars; CE Eligible Compounding; Drug Regulatory Process; Generic Drugs

 

Resources for You


Sub-Topic Paragraphs

Paragraph Header
Contact Us

Contact Point
Office of Communications
10001 New Hampshire Ave
Hillandale Building, 4th Fl
Silver Spring, MD 20993

druginfo@fda.hhs.gov

Toll Free
(855) 543-3784
(301) 796-3400

Hours Available

CDER Division of Drug Information

For Updates on Twitter follow

Contact Point Twitter

@FDA_Drug_Info

Your source for the latest drug information.
Know the moment it happens.


Back to Top